Cassandra Nan

AstraZeneca (Italy) — Italy

Medicine · Health Sciences

12h-index795citations32works8.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(11), Chronic Obstructive Pulmonary Disease (COPD) Research(7), Diabetes Treatment and Management(5), Chronic Kidney Disease and Diabetes(4), Renal Diseases and Glomerulopathies(4)

Publications32 total

Anifrolumab Study for Treatment Effectiveness in the Real World (ASTER) among patients with systemic lupus erythematosus: protocol for an international observational effectiveness study
BMJ Open·2024· 1 citedOpen Access
Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan
Advances in Therapy·2024· 15 citedOpen Access
#4494 DRUG UTILIZATION FOLLOWING INCIDENT CHRONIC KIDNEY DISEASE: AN OBSERVATIONAL STUDY IN THE UNITED STATES AND JAPAN
Nephrology Dialysis Transplantation·2023Open Access
#4420 EARLY DAPAGLIFLOZIN UTILIZATION FOR CHRONIC KIDNEY DISEASE TREATMENT IN JAPAN
Nephrology Dialysis Transplantation·2023Open Access
AB0546 DESIGN OF ANIFROLUMAB STUDY OF TREATMENT EFFECTIVENESS IN THE REAL WORLD (ASTER): A MULTI-NATIONAL, OBSERVATIONAL, POST-LAUNCH STUDY TO DESCRIBE THE CLINICAL EFFECTIVENESS OF ANIFROLUMAB IN ROUTINE CLINICAL PRACTICE IN PATIENTS WITH SLE
Annals of the Rheumatic Diseases·2023Open Access
Dapagliflozin Initiation and eGFR Trajectories Across uACR Subgroups in Clinical Practice
Metabolism·2023
Early Dapagliflozin Utilization for CKD Treatment in the United States
Journal of the American Society of Nephrology·2022
Regional variation in prevalence of difficult-to-treat asthma and oral corticosteroid use for patients in Australia: heat map analysis
Journal of Asthma·2022· 3 citedOpen Access
Regional variation in intensity of inhaled asthma medication and oral corticosteroid use in Denmark, Finland, and Sweden
European Clinical Respiratory Journal·2022· 6 citedOpen Access
German regional variation of acute and high oral corticosteroid use for asthma
Journal of Asthma·2021· 8 cited
Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program
Advances in Therapy·2020· 115 citedOpen Access
German Regional Variation of Acute and High Oral Corticosteroid Use for Asthma
2020Open Access
Regional Variation in Asthma Prevalence and Oral Corticosteroid Use for Canadian Patients: Heat Map Analysis
2020· 2 cited
Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK
European Respiratory Journal·2020· 55 citedOpen Access
Short-term and Maintenance Oral Corticosteroid Use for German Patients with Asthma
Pneumologie·2020· 1 cited
SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries
Advances in Therapy·2020· 138 citedOpen Access
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β<sub>2</sub>-agonist use in asthma
European Respiratory Journal·2019· 60 citedOpen Access
P144 Regional variation in OCS use for UK patients with asthma: heat map analysis
2019· 2 cited
Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma
Epidemiology·2019
Oral corticosteroid prescription patterns in asthma care in Italy
2019
page 1 of 2Next →

Frequent Co-authors

Jennifer K Quint(4), Maurice P. Zeegers(4), Olaf Schmidt(4), Robert Lindner(4), Yasemin Ilgin(4), Thomas Schultz(4), Lykke Hinsch Gylvin(4), Navdeep Tangri(3), Tadashi Sofue(3), Eugene R. Bleecker(3), Andrew Menzies‐Gow(2), Claudia Cabrera(2), Sofie Arnetorp(2), Ralf J.P. van der Valk(2), Claire Warner(2), Tom Fowler(2), Timothy Barrett(2), Dorret I. Boomsma(2), Gastón Beunen(2), Martine Thomis(2)